| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11% | $17,696,249 | 4,284,806 | SUVRETTA CAPITAL MANAGEMENT, LLC | 15 Jun 2021 | |||
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.8% | $8,020,830 | 2,144,607 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 30 Sep 2024 |
As of 30 Sep 2025, 6 institutional investors reported holding 3,581,480 shares of MOLECULAR PARTNERS AG - Common Shares (MOLN). This represents 9.7% of the company’s total 36,975,983 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 3,581,480 | $13,287,291 | -$17,608 | $3.71 | 6 |
| 2025 Q2 | 3,586,226 | $13,712,923 | +$13,762 | $3.82 | 6 |
| 2025 Q1 | 3,582,606 | $14,158,038 | -$1,412 | $3.88 | 6 |
| 2024 Q4 | 3,582,970 | $17,041,735 | +$12,999,805 | $4.75 | 5 |
| 2024 Q3 | 849,236 | $4,201,691 | -$83,370 | $5.09 | 5 |
| 2024 Q2 | 860,199 | $6,183,756 | -$613,321 | $7.23 | 8 |
| 2024 Q1 | 945,699 | $3,829,491 | -$42,959 | $3.88 | 8 |
| 2023 Q4 | 956,492 | $3,906,862 | -$15,745 | $4.00 | 8 |
| 2023 Q3 | 960,448 | $3,907,242 | +$97,785 | $4.00 | 7 |
| 2023 Q2 | 929,499 | $5,726,664 | -$4,809 | $6.11 | 7 |
| 2023 Q1 | 930,313 | $5,597,356 | +$63,804 | $6.02 | 6 |
| 2022 Q4 | 919,479 | $5,989,241 | -$23,299 | $6.55 | 8 |
| 2022 Q3 | 921,787 | $6,172,000 | +$69,703 | $6.69 | 8 |
| 2022 Q2 | 878,797 | $5,935,000 | -$9,722,305 | $6.75 | 8 |
| 2022 Q1 | 1,354,636 | $27,569,000 | +$3,934,206 | $20.26 | 8 |
| 2021 Q4 | 1,161,423 | $22,356,000 | -$4,780,943 | $19.29 | 9 |
| 2021 Q3 | 1,407,964 | $27,697,000 | -$6,462,996 | $19.61 | 9 |
| 2021 Q2 | 1,716,979 | $35,145,000 | +$35,145,004 | $20.49 | 14 |